GEODE CAPITAL MANAGEMENT, LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 37 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$564,597
-29.3%
218,778
+18.3%
0.00%
Q2 2023$798,638
+182.4%
184,8700.0%0.00%
Q1 2023$282,851
+96766.8%
184,8700.0%0.00%
Q4 2022$292
-99.9%
184,870
-0.2%
0.00%
Q3 2022$229,000
-35.9%
185,219
+4.6%
0.00%
Q2 2022$357,000
-18.3%
177,022
+1.2%
0.00%
Q1 2022$437,000
-30.1%
174,858
+4.2%
0.00%
Q4 2021$625,000
-7.0%
167,7630.0%0.00%
Q3 2021$672,000
+13.1%
167,763
+25.6%
0.00%
Q2 2021$594,000
-49.4%
133,569
+4.0%
0.00%
Q1 2021$1,175,000
+11.8%
128,468
+23.9%
0.00%
Q4 2020$1,051,000
+296.6%
103,699
+65.5%
0.00%
Q3 2020$265,000
-32.1%
62,662
+11.1%
0.00%
Q2 2020$390,000
+142.2%
56,412
-1.9%
0.00%
Q1 2020$161,000
-5.3%
57,524
+63.8%
0.00%
Q4 2019$170,000
+448.4%
35,114
+128.0%
0.00%
Q3 2019$31,00015,3990.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders